Home › Stocks › DNA › All Fund Holders
DNA — GINKGO BIOWORKS HOLDINGS INC · All Fund Holders
Funds holding (latest): 38 · Reported value held: $214.63M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 4.28M | $42.44M | 0.00% | Add |
| Viking Global Investors history | Q2 2026 | 3.58M | $35.45M | 0.10% | Hold |
| Vanguard Group history | Q4 2025 | 2.90M | $24.11M | 0.00% | Add |
| Baillie Gifford & Co history | Q2 2026 | 2.39M | $23.70M | 0.02% | Hold |
| Legal & General Investment Management America history | Q2 2026 | 1.67M | $16.54M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 1.22M | $12.11M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 691.66K | $6.85M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 638.68K | $6.33M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 621.62K | $6.16M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 607.38K | $6.02M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 545.85K | $5.41M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 539.86K | $5.35M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 405.14K | $4.01M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 394.61K | $3.91M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 274.33K | $2.72M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 211.72K | $2.10M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 170.48K | $1.69M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 151.36K | $1.50M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 144.31K | $1.43M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 134.04K | $1.37M | 0.00% | New |
| Marshall Wace history | Q2 2026 | 77.94K | $772.36K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 65.12K | $645.37K | 0.00% | Add |
| Point72 Asset Management history | Q4 2025 | 76.91K | $639.11K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 60.45K | $599.10K | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 47.09K | $466.66K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 45.83K | $454.14K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 41.91K | $415.31K | 0.00% | Add |
| Casdin Capital history | Q2 2026 | 36.49K | $361.65K | 0.02% | Hold |
| Balyasny Asset Management history | Q4 2025 | 37.98K | $315.59K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 22.50K | $222.97K | 0.00% | New |
| Franklin Resources history | Q2 2026 | 16.77K | $166.22K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 12.88K | $127.69K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 14.53K | $88.95K | 0.00% | Hold |
| Soros Fund Management history | Q1 2022 | 80.00K | $70.00K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 6.95K | $68.88K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 444 | $4.40K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 93.53K | $927 | 0.00% | Reduce |
| Lazard Asset Management history | Q4 2024 | 427 | $4 | 0.00% | New |